Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neuroscience
Pharma
AbbVie will continue to pursue external innovation for long-term
Amid reports that AbbVie is angling for a $1B buyout of neuroscience specialist Gilgamesh, the company revealed booming sales of Skyrizi and Rinvoq.
Kevin Dunleavy
Jul 31, 2025 11:44am
BMS' schizophrenia drug stumbles in blow to blockbuster plan
Apr 23, 2025 10:35am
Even through its remake, Alkermes retains upward trajectory: CEO
Jan 13, 2025 7:36am
A revival in neuro therapeutics
Oct 11, 2024 8:37am
BMS wins FDA approval for new schizophrenia med Cobenfy
Sep 26, 2024 7:38pm
Neurocrine elevates BD chief to succeed founder and CEO
May 29, 2024 11:42am
